The Diabetes Collaborative Registry is the first global, cross-specialty clinical diabetes registry designed to track and improve the quality of diabetes and metabolic care across the primary care and specialty care continuum.

Partners

Get Started

Learn more about how to register

GO

The registry is an interdisciplinary collaboration led by the American College of Cardiology in partnership with the American Association for Clinical Endocrinologists, American Diabetes Association, the American College of Physicians and the Joslin Diabetes Center. The unique, real-world collaboration among multi-disciplinary providers is designed to help transform the future of diabetes treatment and prevention and improve the lives of billions.
 
A major health epidemic, diabetes kills more Americans each year than AIDS and breast cancer combined.  Nearly 30 million children and adults, or 10 percent of Americans, have diabetes. Another 86 million have prediabetes, which indicates that those individuals are already at high risk of developing type 2 diabetes. Meanwhile, one out of four people currently do not know they have diabetes at all. If allowed to continue unchecked, it is estimated that the number of Americans with diabetes will triple by 2050. 

Diabetes is not merely a health-related issue but a socio-economic one as well. In the United States, medical costs for people with diabetes are more than twice as high as those for individuals without it.  The estimated medical costs and lost wages for people with diabetes totaled $245 billion in 2012, which was greater than a 40 percent increase from what it had been five years prior to that.

Notably, cardiovascular disease (CVD) is the leading cause of death among people with type-2 diabetes – and adults with diabetes are also two to four times more likely to have CVD then those without. The strong correlation between diabetes and CVD means there is much to be gained from a coordinate approach to diabetes patient care. All of the partners involved with the Diabetes Collaborative Registry recognize the importance of consolidating efforts and taking an integrated, coordinated and interdisciplinary approach to this real-world problem. 

In addition to individual providers, government leaders and agencies will be able to leverage the Diabetes Collaborative Registry to transform clinical data into actionable insights to improve health outcomes; accelerate access to care solutions that advance patient safety; improve rates of compliance and surveillance; and, ultimately impact populations at scale.